Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23469321 | 0.85 | — | — | |
| SCHEMBL126033 | 0.82 | LMNA (0.33) | LMNAALDH1A1HSD17B10 | |
| SCHEMBL465965 | 0.82 | LMNA (0.33) | LMNAALDH1A1HSD17B10 | |
| SCHEMBL27614377 | 0.82 | ALOX15 (0.34) | ALOX15LMNACYP2D6CYP2C9CYP2C19 | |
| SCHEMBL24199889 | 0.79 | — | — | |
| SCHEMBL7212725 | 0.78 | LMNA (0.31) | LMNA | |
| SCHEMBL2197998 | 0.77 | TDP1 (0.31) | ALOX15LMNA | |
| SCHEMBL20542144 | 0.74 | ALDH1A1 (0.38) | LMNAALDH1A1 | |
| SCHEMBL16322664 | 0.74 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL17565591 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12611016-B2 | Cationic contact lens | COOPERVISION INTERNATIONAL LIMITED (GB) | 2026-04-28 | — | — | US | claimed |
| US-12601929-B2 | Contact lens | COOPERVISION INTERNATIONAL LIMITED (GB) | 2026-04-14 | — | — | US | claimed |
| EP-4413404-B1 | CATIONIC CONTACT LENS | COOPERVISION INT LTD (GB) | 2025-10-15 | — | — | EP | claimed |
| EP-4537135-B1 | CONTACT LENS AND PACKAGING SOLUTION | COOPERVISION INT LTD (GB) | 2025-09-17 | — | — | EP | claimed |
| EP-4413405-B1 | SUSTAINED RELEASE OF OLEIC ACID FROM CONTACT LENSES | COOPERVISION INT LTD (GB) | 2025-06-18 | — | — | EP | claimed |
| WO-2025088339-A1 | CONTACT LENS WITH TRPM8 AGONIST IS RELEASABLY ADHERED TO THE POLYMERIC LENS BODY | COOPERVISION INTERNATIONAL LIMITED (GB) | 2025-05-01 | — | — | WO | claimed |
| US-12282209-B1 | Contact lens and packaging solution | COOPERVISION INTERNATIONAL LIMITED (GB) | 2025-04-22 | — | — | US | claimed |
| EP-4537135-A1 | CONTACT LENS AND PACKAGING SOLUTION | CooperVision International Limited (GB) | 2025-04-16 | — | — | EP | claimed |
| EP-4388349-B1 | CONTACT LENS | COOPERVISION INT LTD (GB) | 2025-03-12 | — | — | EP | claimed |
| CN-116391140-B | Cationic contact lens | 库博光学国际有限公司 | 2025-01-10 | — | — | CN | claimed |
| WO-2022129871-A1 | CATIONIC CONTACT LENS | COOPERVISION INTERNATIONAL LIMITED (GB) | 2022-06-23 | — | — | WO | claimed |
| US-20220183433-A1 | CATIONIC CONTACT LENS | COOPERVISION INTERNATIONAL LIMITED (GB) | 2022-06-16 | — | — | US | claimed |
| EP-2681614-B1 | WETTABLE SILICONE HYDROGEL CONTACT LENSES | COOPERVISION INT LTD (GB) | 2021-05-05 | — | — | EP | claimed |
| US-9164298-B2 | Wettable silicone hydrogel contact lenses | COOPERVISION INTERNATIONAL HOLDING COMPANY, LP (BB) | 2015-10-20 | — | — | US | claimed |
| US-8865789-B2 | Silicone hydrogel contact lenses | COOPERVISION INTERNATIONAL HOLDING COMPANY, LP (BB) | 2014-10-21 | — | — | US | claimed |
| US-20140022506-A1 | Wettable Silicone Hydrogel Contact Lenses | COOPER VISION INTERNATIONAL HOLDING COMPANY ,LP (BB) | 2014-01-23 | — | — | US | claimed |
| WO-2012118678-A1 | WETTABLE SILICONE HYDROGEL CONTACT LENSES | COOPERVISION INTERNATIONAL HOLDING COMPANY, LP (BB) | 2012-09-07 | — | — | WO | claimed |
| WO-2012118674-A2 | SILICONE HYDROGEL CONTACT LENSES | COOPERVISION INTERNATIONAL HOLDING COMPANY, LP (BB) | 2012-09-07 | — | — | WO | claimed |
| US-20120220689-A1 | Silicone Hydrogel Contact Lenses | COOPERVISION INTERNATIONAL HOLDING COMPANY, LP (BB) | 2012-08-30 | — | — | US | claimed |
| EP-2492718-A1 | Silicone Hydrogel Contact Lenses | CooperVision International Holding Company, LP (BB) | 2012-08-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12601929-B2 | Contact lens | TRPM8, TRPM7, TRPM5 | ALOX15 258/4885LMNA 1959/4885CYP2D6 4432/4885 |
| US-12611016-B2 | Cationic contact lens | SMCHD1, SSB, SMC2 | ALOX15 2891/4885LMNA 324/4885CYP2D6 4573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.